Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Abstracts In Press
    • Archives
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Brief ReportBrief Report

Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care

Andrew L. Sussman, Jennifer N. Crawford, Heidi Rishel Brakey, Rana S. Alkhafaji, Orrin B. Myers, Vanessa Jacobsohn, Snehal Bhatt and Julie Salvador
The Journal of the American Board of Family Medicine November 2021, 34 (6) 1216-1220; DOI: https://doi.org/10.3122/jabfm.2021.06.210111
Andrew L. Sussman
From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).
PhD, MCRP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer N. Crawford
From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidi Rishel Brakey
From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rana S. Alkhafaji
From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Orrin B. Myers
From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vanessa Jacobsohn
From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Snehal Bhatt
From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Salvador
From the Department of Family and Community Medicine and University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque (ALS); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (JNC); Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque (HRB); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (RSA); Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque (OBM); Department of Psychiatry & Behavioral Sciences, University of New Mexico Health Sciences Center, Albuquerque (VJ, SB, JS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Benchmark Tracking Assessment Stages, Enrollment Status, and Benchmark Achievement

    Benchmark Tracking Assessment StageMAT Continuum StageNever Missed a Benchmark (n = 20) Count (%)Missed at Least 1 Benchmark (n = 21) Count (%)Total (n = 41) Count (%)
    1. PrewaiverTraining and licensing10 (50.0)14 (66.7)24 (58.5)
    2. Between waiver and license2 (10.0)0 (0.0)2 (4.9)
    3. Between license and prescribing2 (10.0)3 (14.3)5 (12.2)0 (0.0)
    4. Prescribing to 1 patientActively prescribing0 (0.0)0 (0.0)0 (0.0)
    5. Prescribing to multiple patients6 (30.0)4 (19.0)10 (24.4)0 (0.0)
    • MAT, medication-assisted treatment.

    • View popup
    Table 2.

    Participant Demographics (n = 41)

    Gendern (%)
    Male18 (43.9)
    Female23 (56.1)
    Race
        American Indian/Alaska Native1 (2.4)
        Asian2 (4.9)
        Black, African American2(4.9)
        Hawaiian/Pacific Islander0 (0)
        Non-Hispanic White34 (82.9)
        Other2 (4.9)
    Hispanic/non-Hispanic
        Hispanic/Latinx6 (14.6)
        Non-Hispanic/Latinx35 (85.4)
    Rural
        Yes41 (100.0)
        No0 (0.0)
    Prescriber Degree
        Medical Doctor/Doctor of Osteopathic Medicine18 (43.9)
        Nurse practitioner20 (48.8)
        Physician assistant3 (7.3)
    • View popup
    Table 3.

    Facilitation Opportunities at Each Benchmark Stage

    MAT Continuum StageNever Missed a Benchmark (n = 20) Count (%)Missed at Least 1 Benchmark (n = 21) Count (%)Total (n = 41) Count (%)
    Number of facilitation opportunities*4162103
    Accepted41 (100.0)35 (56.5)76 (73.8)
    Average per provider3.73.03.2
    Benchmark stage
    1. PrewaiverTraining and licensing1 (2.4)22 (35.5)23 (22.3)
    2. Between waiver and license0 (0.0)2 (3.2)2 (1.9)
    3. Between license and prescribing14 (34.1)12 (19.4)26 (25.2)0 (0.0)
    4. Prescribing to 1 patientActively prescribing0 (0.0)1 (1.6)1 (1.0)
    5. Prescribing to multiple patients26 (63.4)25 (40.3)51 (49.5)0 (0.0)
    Totals41 (100)62 (100)103 (100)
    • MAT, medication-assisted treatment.

    • ↵* Offers (ie, after missed benchmark) or requests for facilitation.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family   Medicine: 34 (6)
The Journal of the American Board of Family Medicine
Vol. 34, Issue 6
November/December 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care
Andrew L. Sussman, Jennifer N. Crawford, Heidi Rishel Brakey, Rana S. Alkhafaji, Orrin B. Myers, Vanessa Jacobsohn, Snehal Bhatt, Julie Salvador
The Journal of the American Board of Family Medicine Nov 2021, 34 (6) 1216-1220; DOI: 10.3122/jabfm.2021.06.210111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Use of a Benchmark Tracking Assessment to Support Expansion of Buprenorphine for Treatment of Opioid Use Disorder in Primary Care
Andrew L. Sussman, Jennifer N. Crawford, Heidi Rishel Brakey, Rana S. Alkhafaji, Orrin B. Myers, Vanessa Jacobsohn, Snehal Bhatt, Julie Salvador
The Journal of the American Board of Family Medicine Nov 2021, 34 (6) 1216-1220; DOI: 10.3122/jabfm.2021.06.210111
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Research on the Issues Family Physicians Face Today: Controlled Substances, COVID-19, Hypertension, and "Slow Medicine," Among Many More Topics
  • Google Scholar

More in this TOC Section

  • Association of Social Needs with Diabetes Outcomes in an Older Population
  • Insurance Instability Among Community-Based Health Center Patients with Diabetes Post-Affordable Care Act Medicaid Expansion
  • Factors Influencing Changing Scopes of Practice Among Contemporary Graduates of the Nation’s Largest Family Medicine Residency
Show more Brief Reports

Similar Articles

Keywords

  • Access to Health Care
  • Benchmarking
  • Buprenorphine
  • Extensions for Community Healthcare Outcomes (ECHO)
  • Internet-Based Intervention
  • Medication-Assisted Treatment of Opioid
  • Opioid-Related Disorders
  • Opioids
  • Primary Health Care

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire